Why study with us?
Our strong clinical partnership with the National Hospital for Neurology and Neurosurgery gives us a privileged understanding of how to bring a truly patient-focused approach to research, innovation and education.
We are a world leader in neuroscience
UCL is the top-rated university in the UK for research power (REF 2014), and we are home to one of the largest groups of neuroscience experts in the world
UCL is 1st in Europe and 2nd in the world for neuroscience and behaviour, based entirely on quantitative data relating to scientific papers (2020 National Taiwan University report)
UCL is 1st in Europe and 2nd worldwide for citations in neuroscience and behaviour, with more than twice as many published papers as any other European university (InCites Essential Scientific Indicators 2020)
UCL is 1st for neuroscience in the REF, with more than 80% of our research rated as world-leading (4*) or internationally excellent (3*) (UK’s Research Excellence Framework)
12 of our professors are named as being among the most influential academics in the world (Clarivate Web of Science’s ‘Highly Cited Researchers 2020’)
We are home to a Nobel Prizewinner (James Rothman) and Professor Ray Dolan was awarded the Brain Prize in 2017, followed by Professors John Hardy and Bart De Strooper in 2018. It was unprecedented for academics from the same institution to be awarded the coveted prize two years in a row.
Neuroscience accounts for more than 33% of UCL’s entire research income, with 130 principal investigators leading our research
We are the hub of the UK Dementia Research Institute (UK DRI), the single biggest investment the UK has ever made in dementia thanks to £290 million from founding funders the Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK
Our central London location gives access to one of the world’s most vibrant, cosmopolitan and influential cities, ranked as the best city in the world for university students (QS Best Student Cities 2022)
"I really enjoyed having the opportunity to join senior clinicians on ward rounds, meet patients with very interesting cases and observe how experienced neurologists interact with them."
"I believe that UCL and UCL Queen Square Institute of Neurology (IoN) are leading the charge for neuroscience and neurological research."
"UCL Brain Sciences consists of internationally renowned scientists who contribute to ground-breaking discoveries and offers world-class facilities not found under one hood elsewhere in the world."
"The lecturers and my fellow peers are a daily inspiration. Being surrounded by such passionate researchers and clinicians is hugely motivating and has exposed me to a different world!"
"I deeply appreciate the meritocracy and transparency that characterise learning and research at UCL and, more generally, in the UK."
We have one of the strongest and broadest clinical dementia programmes internationally, with major strength in unmatched clinical cohorts, expertise and biological resources. Our unique academic health science partnerships provide us with access to a patient population of over six million, including the longest continually running major birth cohort study in the world.
Our research platforms include imaging, biobank cells and DNA, big data platforms, high throughput technology, computational neuroscience, molecular biology, disease modelling, genetics, and the Drug Discovery Institute.
Our programmes span the full spectrum of common and rare neurological conditions, including dementia, stroke, epilepsy, multiple sclerosis, motor neuron disease, Parkinson’s disease, migraine, brain tumours and neuromuscular diseases.